Zolmitriptan

FDA Approved: * March 4, 2014
Pharm Company: * TEVA PHARMS
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zolmitriptan Overview

Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches. Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Argentina, Canada & Greece), AscoTop (Germany) and Zomigoro (France). In 2008, Zomig generated nearly $154 million in sales.[1] AstraZeneca's U.S. patent on Zomig tablets expired on November 14, 2012, and its ...

Read more Zolmitriptan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Zolmitriptan

Recent Zolmitriptan Forums: RSS Feed

round white pill with the imprint z5 on one side, and just a line on the other side

tablet ## This is Zolmitriptan 5mgs, a generic for Zomig. This is used to help treat and prevent migraines. Common side effects include dry mouth, jay stiffness and chest pain.

Updated

Possible Dosages for this and Related Drugs:

Zolmitriptan
  • Aerosol, Metered: 5mg/actuation
  • Solution: 5mg/actuation
  • Spray: 2.5mg/spray, 5mg/spray
  • Tablet: 2.5mg, 5mg
  • Tablet, Orally Disintegrated: 2.5mg, 5mg
  • Tablet, Orally Disintegrating: 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zolmitriptan: (56 results)

Showing the first 20, Sorted by National Drug Code
  • 0115-0671 Zolmitriptan 2.5 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.
  • 0115-0672 Zolmitriptan 5 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.
  • 0115-0691 Zolmitriptan 2.5 mg Disintegrating Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.
  • 0115-0692 Zolmitriptan 5 mg Disintegrating Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.
  • 0310-0209 Zomig-zmt 2.5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
  • 0310-0213 Zomig-zmt 5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
  • 0378-4260 Zolmitriptan 2.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-4261 Zolmitriptan 5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 27241-021 Zolmitriptan 2.5 mg Oral Tablet by Ajanta Pharma Limited
  • 27241-022 Zolmitriptan 5 mg Oral Tablet by Ajanta Pharma Limited
  • 31722-458 Zolmitriptan 2.5 mg Oral Tablet, Film Coated by Camber Pharmaceuticals Inc
  • 31722-459 Zolmitriptan 5 mg Oral Tablet, Film Coated by Camber Pharmaceuticals Inc
  • 33342-112 Zolmitriptan 2.5 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-113 Zolmitriptan 5 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-139 Zolmitriptan 2.5 mg Oral Tablet, Orally Disintegrating by Macleods Pharmaceuticals Limited
  • 33342-140 Zolmitriptan 5 mg Oral Tablet, Orally Disintegrating by Macleods Pharmaceuticals Limited
  • 46708-181 Zolmitriptan 2.5 mg Oral Tablet, Orally Disintegrating by Alembic Pharmaceuticals Limited
  • 46708-182 Zolmitriptan 5 mg Oral Tablet, Orally Disintegrating by Alembic Pharmaceuticals Limited
  • 46708-462 Zolmitriptan 2.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 46708-463 Zolmitriptan 5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 36 more results ...

Other drugs which contain Zolmitriptan or a similar ingredient: (2 results)

Related Zolmitriptan Topics:

zolmitriptan
label of ascotop and zomig...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA